To examine the effects of representative NHI-based LDH-A inhibitors NHI-1 and NHI-2 on GBM cell viability, U87MG cells were treated with different concentrations of LDH-A inhibitors (10 nM − 50 μM) for 24 or 48 h. The gene discussed is LDHA; the disease is glioblastoma.